
Prognostix AB has developed a decision support tool (www.pathfx.org), capable of estimating survival in cancer patients with skeletal metastases. PATHFx is based on Machine Learning and helps physicians personalize care more effectively, thereby improving patient quality of life and reduce health care costs. PATHFx has sucessfully been tested at many renowned cancer centers globally.
We are part of KI Innovations Incubator/Accelerator DRIVE.
Milestones titleThis text is hidden in the job ads. Edit the title from the field above.
Lorem ipsumFusce volutpat consequat velit, sed scelerisque lorem egestas a. Vestibulum ut odio sagittis, aliquam sapien a, pulvinar nisi. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsumLorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam lobortis libero sed malesuada dictum. Fusce volutpat consequat velit, sed scelerisque lorem egestas a.
Lorem ipsumVestibulum ut odio sagittis, aliquam sapien a, pulvinar nisi. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Maecenas blandit, tortor sed finibus
Est metus eleifend justo
In facilisis nunc ac lectus fermentum
Quisque ultrices blandit quam
Aenean interdum nisl vitae justo
Praesent tincidunt vitae nisi et rhoncus